Overview

Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety after administration of MP-424 to patients with chronic hepatitis C.
Phase:
Phase 2
Details
Lead Sponsor:
Mitsubishi Tanabe Pharma Corporation
Collaborator:
Vertex Pharmaceuticals Incorporated